Cargando…
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response
Cytogenetic abnormalities are found in most multiple myeloma (MM) patients. Although their prognostic value has been well studied, there are limited data on the association of primary cytogenetic abnormalities with disease characteristics and treatment response. This study was designed to evaluate t...
Autores principales: | Abdallah, Nadine, Rajkumar, S. Vincent, Greipp, Patricia, Kapoor, Prashant, Gertz, Morie A., Dispenzieri, Angela, Baughn, Linda B., Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Go, Ronald S., Hwa, Yi L., Fonder, Amie, Hobbs, Miriam, Lin, Yi, Leung, Nelson, Kourelis, Taxiarchis, Warsame, Rahma, Siddiqui, Mustaqeem, Lust, John, Kyle, Robert A., Bergsagel, Leif, Ketterling, Rhett, Kumar, Shaji K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419564/ https://www.ncbi.nlm.nih.gov/pubmed/32782240 http://dx.doi.org/10.1038/s41408-020-00348-5 |
Ejemplares similares
-
P-208: Association of thrombocytopenia with disease burden, high-risk cytogenetics, and survival in newly diagnosed multiple myeloma patients
por: Charalampous, Charalampos, et al.
Publicado: (2022) -
A simple additive staging system for newly diagnosed multiple myeloma
por: Abdallah, Nadine H., et al.
Publicado: (2022) -
Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patients
por: Rajkumar, S, et al.
Publicado: (2023) -
P-207: Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
por: Charalampous, Charalampos, et al.
Publicado: (2022) -
Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
por: Charalampous, Charalampos, et al.
Publicado: (2022)